Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Filgrastim, ATC L03AA02 für die Zeit 01.04.2024 - 31.03.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 101 Carefarm GmbH, 1 4 U Pharma GmbH, 2care4 ApS, Aaragon Pharma s.r.o, Abacus Medicine A/S, ACA Müller ADAG Pharma AG, Accord Healthcare SLU vertreten durch die Accord Healthcare GmbH, adequapharm GmbH, axicorp Pharma B.V., axicorp Pharma GmbH, CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, HEXAL AG, INOPHA GmbH, kohlpharma GmbH, Medicopharm AG, Orifarm GmbH, Originalis B.V., Pfizer Pharma GmbH, ratiopharm GmbH, SynCo Pharma B.V.
- Contract value
- no value published
- Bids received
- 19
- Published
- 16 Jun 2026
- Awarded
- 1 Apr 2025
- Contract start
- 1 Apr 2025
- Contract end
- 14 Apr 2026estimated
- Region
- Hamburg